Trilaciclib With Platinum-based Chemotherapy Followed by Avelumab Maintenance as First-line Treatment in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: PRESERVE 3 Phase II Trial
Trilaciclib With Platinum-based Chemotherapy Followed by Avelumab Maintenance as First-line Treatment in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: PRESERVE 3 Phase II Trial. // Clinical Genitourinary Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S1558767326001928?dgcid=rss_sd_all
Trilaciclib With Platinum-based Chemotherapy Followed by Avelumab Maintenance as First-line Treatment in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: PRESERVE 3 Phase II Trial. Clinical Genitourinary Cancer. https://www.sciencedirect.com/science/article/pii/S1558767326001928?dgcid=rss_sd_all
“Trilaciclib With Platinum-based Chemotherapy Followed by Avelumab Maintenance as First-line Treatment in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: PRESERVE 3 Phase II Trial.” Clinical Genitourinary Cancer.
@article{article41363,
title = {Trilaciclib With Platinum-based Chemotherapy Followed by Avelumab Maintenance as First-line Treatment in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: PRESERVE 3 Phase II Trial},
journal = {Clinical Genitourinary Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S1558767326001928?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...